Hims & Hers Health Inc.(以下简称"Hims & Hers")在今日盘后交易中大涨8.38%,引发市场广泛关注。公司刚刚公布了前三季度的业绩报告,成绩出色的背后离不开Hims & Hers在主营业务上的突出表现。
财报显示,Hims & Hers前三季度净利润达1亿美元,较去年同期实现扭亏为盈。其营收同比增长58.9%至9.954亿美元,主要来自在线销售渠道的处方药和非处方产品。高达80.7%的毛利率为公司获取更多利润奠定了基础。
出色的业绩说明了Hims & Hers在远程医疗服务领域的竞争优势。公司致力于为患者提供更加便捷的诊疗渠道,产品和服务广受好评。良好的财务状况和强劲增长潜力增强了投资者对其未来发展前景的信心,推动股价在盘后一路飙升。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.